威尔药业
(603351)
| 流通市值：38.33亿 | | | 总市值：38.33亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 243,388,554.83 | 247,200,482.38 | 169,866,020.06 | 173,214,813 |
| 应收票据及应收账款 | 221,302,802.8 | 202,052,586.3 | 193,302,097.11 | 241,249,914.37 |
| 应收账款 | 221,302,802.8 | 202,052,586.3 | 193,302,097.11 | 241,249,914.37 |
| 应收款项融资 | 37,586,289.65 | 36,336,447.92 | 50,857,741.82 | 44,876,923.34 |
| 预付款项 | 27,185,805.52 | 19,849,172.12 | 25,669,470.84 | 21,891,705.48 |
| 其他应收款合计 | 2,848,375.96 | 4,399,798.51 | 2,659,106.45 | 2,585,858.11 |
| 存货 | 199,170,901.04 | 202,024,559.7 | 152,327,215.97 | 166,702,691.22 |
| 其他流动资产 | 3,512,291.53 | 5,342,005.1 | 4,534,914.97 | 5,092,797.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 734,995,021.33 | 717,205,052.03 | 599,216,567.22 | 655,614,702.88 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 113,412,979.02 | 83,412,979.02 | 83,412,979.02 | 83,412,979.02 |
| 固定资产 | 1,275,991,217.73 | 1,301,864,581.58 | 1,321,587,101.92 | 1,199,768,026.85 |
| 在建工程 | 141,575,534.85 | 128,713,354.03 | 119,038,753.02 | 256,434,223.75 |
| 使用权资产 | 16,555,930.56 | 18,377,011.52 | 20,551,748.11 | 22,726,484.7 |
| 无形资产 | 110,701,479.29 | 111,909,880.46 | 112,795,339.13 | 113,998,190.49 |
| 长期待摊费用 | 988,134.55 | 282,944.05 | 317,053.76 | 325,461.89 |
| 递延所得税资产 | 6,673,224.88 | 6,901,681.31 | 10,741,701.91 | 8,192,973.1 |
| 其他非流动资产 | 23,098,129.49 | 12,246,435.67 | 11,776,165.44 | 4,905,321.27 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,688,996,630.37 | 1,663,708,867.64 | 1,680,220,842.31 | 1,689,763,661.07 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,423,991,651.7 | 2,380,913,919.67 | 2,279,437,409.53 | 2,345,378,363.95 |
| 流动负债: | | | | |
| 短期借款 | 417,194,108.33 | 376,199,318.06 | 331,185,736.11 | 403,607,708.33 |
| 应付票据及应付账款 | 91,037,461.15 | 98,757,278.22 | 84,441,407.51 | 102,526,684.66 |
| 应付账款 | 91,037,461.15 | 98,757,278.22 | 84,441,407.51 | 102,526,684.66 |
| 合同负债 | 4,615,758.7 | 5,397,746.3 | 10,387,871.14 | 9,391,336.91 |
| 应付职工薪酬 | 10,562,980.58 | 31,195,954.84 | 15,809,452.1 | 13,796,365.48 |
| 应交税费 | 14,713,470.07 | 8,362,999.06 | 9,541,598.08 | 13,194,240.61 |
| 其他应付款合计 | 17,162,909.63 | 17,559,824.97 | 15,160,570.68 | 26,833,435.02 |
| 一年内到期的非流动负债 | 25,351,096.61 | 57,727,454.79 | 48,181,185.17 | 47,444,221.6 |
| 其他流动负债 | 2,607,505.06 | 700,381.01 | 1,346,380.05 | 1,220,873.79 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 583,245,290.13 | 595,900,957.25 | 516,054,200.84 | 618,014,866.4 |
| 非流动负债: | | | | |
| 长期借款 | 55,000,000 | 35,000,000 | 44,500,000 | 52,500,000 |
| 租赁负债 | 10,903,120 | 12,321,608.4 | 15,074,244.9 | 15,932,385.13 |
| 递延收益 | 14,270,867.67 | 13,875,867.68 | 13,163,081.64 | 13,296,031.65 |
| 递延所得税负债 | 16,085,358.88 | 15,617,228.75 | 14,809,597.91 | 14,579,765.75 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 96,259,346.55 | 76,814,704.83 | 87,546,924.45 | 96,308,182.53 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 679,504,636.68 | 672,715,662.08 | 603,601,125.29 | 714,323,048.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 135,439,132 | 135,439,132 | 135,439,132 | 135,439,132 |
| 资本公积 | 942,901,810.76 | 942,901,810.76 | 942,901,810.78 | 942,370,834.53 |
| 减:库存股 | - | - | - | 12,788,419.2 |
| 专项储备 | 687,186.81 | 164,607.92 | 1,977,286.93 | 3,833,649.07 |
| 盈余公积 | 67,719,566 | 67,719,566 | 60,958,614.65 | 60,958,614.65 |
| 未分配利润 | 592,286,310.93 | 555,698,747.78 | 528,935,171.78 | 494,933,115.79 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,739,034,006.5 | 1,701,923,864.46 | 1,670,212,016.14 | 1,624,746,926.84 |
| 少数股东权益 | 5,453,008.52 | 6,274,393.13 | 5,624,268.1 | 6,308,388.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,744,487,015.02 | 1,708,198,257.59 | 1,675,836,284.24 | 1,631,055,315.02 |
| 负债和股东权益合计 | 2,423,991,651.7 | 2,380,913,919.67 | 2,279,437,409.53 | 2,345,378,363.95 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-24 | 2024-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |